Shares of Vivos Therapeutics Inc. (VVOS) have gained more than 50% over the last 2 months and trade around $4. However, this is still a 50% decline from the 52-week high of $9.13, which was recorded last January.
This medical technology and services company provides proprietary oral appliances and therapeutic treatments designed to non-surgically address specific maxillofacial and developmental abnormalities of the mouth and jaws, which are often linked to breathing and sleep disorders like mild to severe obstructive sleep apnea (OSA) and snoring in adults.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.